Ameriprise
LUNG icon

Ameriprise’s Pulmonx LUNG Stock Holding History

Ameriprise’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-47,625
Closed -$701K – 4002
2022
Q2 		$701K Sell
47,625
-15,805
-25% -$326K ﹤0.01% 3264
2022
Q1 		$1.57M Buy
63,430
+105
+0.2% +$2.71K ﹤0.01% 3017
2021
Q4 		$2.03M Buy
63,325
+16,500
+35% +$603K ﹤0.01% 2952
2021
Q3 		$1.69M Sell
46,825
-2,600
-5% -$102K ﹤0.01% 2938
2021
Q2 		$2.18M Hold
49,425
– – ﹤0.01% 2893
2021
Q1 		$2.26M Buy
49,425
+1,910
+4% +$110K ﹤0.01% 2808
2020
Q4 		$3.28M Buy
+47,515
New +$2.33M ﹤0.01% 2541

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise's LUNG Position: Q3 2022 in Review

Ameriprise sold out of Pulmonx (LUNG) in Q3 2022, closing a stake of 47,625 shares — an estimated $701K sold.

Ameriprise first reported a position in LUNG in Q4 2020 and held it in 7 quarters. The position peaked at $3.28M in Q4 2020. 104 funds tracked by Wall St. Rank hold LUNG as of Q3 2022.

  • Ameriprise reported no remaining Pulmonx position as of Q3 2022 after selling out during the quarter.
  • Ameriprise sold 47,625 Pulmonx shares in Q3 2022, an estimated $701K.
  • Ameriprise first reported a position in Pulmonx in Q4 2020 and held it in 7 quarters.
  • Ameriprise's Pulmonx position peaked at $3.28M in Q4 2020.
  • 104 funds tracked by Wall St. Rank held Pulmonx as of Q3 2022.

Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.